An underground economy for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.
Experimental Drug Gaining Popularity Online
The experimental drug, which is still in research studies, is being promoted by online personalities for its supposed fat-burning effects. Viewers are encouraged to message these accounts privately for supplier links, while also receiving promotional offers.
Thriving Commerce on Messaging Platforms
Separately, a robust market exists on Telegram, where groups with numerous of members share “before and after” photos, administration instructions and claims of next-day UK delivery. Sellers market the drug there before directing customers to other platforms for purchases.
Understanding The Experimental Drug
This medication is an experimental injectable developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could help individuals lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.
Medical Professionals Express Concerns
However, physicians and pharmacists have cautions that the distribution of what is still an unlicensed medication in the UK is a cause for concern and could result in users injecting products of uncertain source.
Several experts said the demand for retatrutide could be linked to the increasing cost of approved weight loss treatments such as Mounjaro.
Regulatory Status and Enforcement
Selling retatrutide on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that cannot be promoted or distributed for human use under the British medical regulations.
Some influencers attempt to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still breach pharmaceutical, advertising, and customer laws, potentially leading to fines, legal action or prison.
Service Response and Material Elimination
According to TikTok, the platform has taken down problematic material and banned related hashtags and query recommendations. The organization said it was dedicated to maintaining the platform secure and investing in strengthening compliance measures.
Digital Trading Operations
Investigations also discovered groups with up to 9,000 members selling retatrutide using the platform's built-in discovery tool, which operates like a online catalog. Entering “retatrutide” immediately displays groups with numerous of members, filled with images of weight loss, glowing reviews and detailed guides for preparing or injecting at home.
After moments of joining one community, a vendor posted WhatsApp details, where most transactions take place. The vendor sent an instruction manual and promised delivery within two days. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a image of a alleged testing documentation. None inquired about weight, medical conditions or past usage.
Product Information and Pricing
Inside these groups, messages show black plastic packages with Royal Mail labels, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at home with sterile water, or pre-filled pens usually priced at £160 for 20 milligrams. When questioned how much time a injector should be used, sellers give contradictory answers ranging from a few weeks to “depends on your body”.
Service Oversight and Safety Measures
A spokesperson for the messaging service said it actively monitored dangerous content on its service including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are injecting materials they can’t verify. Even if the research behind this drug is sound, these online versions may not contain what they advertise,” stated Jason Murphy, the head of pharmacy at Chemist4U.
A medical professional of an online medical service connected the increase in demand to current cost increases for authorized weight-loss drugs such as Mounjaro. “With prices increasing, patients are using social media. But fake injections are highly dangerous. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she explained.
Her team has already encountered patients harmed by self-injection from unverified suppliers. “We recognize the frustration, but purchasing from Telegram or communication platforms is taking chances with your well-being,” stated the doctor. “These materials could be impure or improperly measured.”
Producer Statement
A spokesperson from Eli Lilly said the substance was in third stage research studies and had not been evaluated or approved by any regulatory agency globally. “Consequently at this point no one can market [it] for human use,” they said, adding that any product “falsely representing itself as a Lilly investigational product not yet approved … may expose users to potentially significant medical dangers”.
